Long-term results back FemSoft urinary insert:
This article was originally published in Clinica
Executive Summary
A one to two year follow-up study from an ongoing trial of Rochester Medical's FemSoft female, single-use stress urinary incontinence device has produced positive results. Interim data from the five year, 150-patient trial indicate a statistically significant reduction in both incontinence episodes and amount of urine loss in patients using the FDA-approved FemSoft insert, notes the Stewartville, Minnesota firm. Notably, some 81% of patients reported that they never or rarely experienced incontinence while using the device. The findings appear in the International Urogynecology Journal (May).